Subsequently, by employing a series of algorithms and integrating the 12 identified CTR-related genes, we created a prognostic prediction signature with both stable and robust accuracy that surpassed a number of previously defined ccRCC risk models. This evidence concerns the gene CALCR and nonpapillary renal cell carcinoma.